Table 1.
Clinical characteristics of the study patients
| Variable | n = 23 |
| Age, y | 68.0 ± 8.7 |
| Women/men, No. (%) | 15 (65.2)/8 (34.8) |
| BMI, kg/m2 | 24.9 ± 4.1 |
| Current smoking, % | 30.4 |
| Habitual drinking, % | 17.4 |
| Previous antihypertensive medication, No. (%) | |
| ARBs | 8 (34.8) |
| Morning administration | 5 (21.7) |
| Evening administration | 3 (13.0) |
| CCBs | 15 (65.2) |
| Morning administration | 15 (65.2) |
| Evening administration | 0 (0) |
| Total cholesterol, mg/dL | 204.8 ± 28.1 |
| High‐density lipoprotein, mg/dL | 64.0 ± 12.7 |
| Triglyceride, mg/dL | 107.6 ± 67.4 |
| Diabetes mellitus, % | 17.4 |
| eGFRcreat, mL/min/1.73 m2 | 68.5 ± 15.7 |
| Urinary albumin excretion | |
| Geometric mean, mg/g·Cr | 77.5 ± 202.8 |
| Mean log‐transformed UACR | 3.04 ± 1.44 |
| Chronic kidney disease, % | 65.2 |
| Blood pressure parameters, mm Hg | |
| Clinic SBP | 154.3 ± 15.4 |
| Clinic DBP | 80.8 ± 8.3 |
| Nocturnal brachial SBP | 122.7 ± 13.0 |
| Nocturnal brachial DBP | 72.4 ± 7.4 |
| Nocturnal central SBP | 113.8 ± 10.7 |
| Nocturnal central DBP | 73.8 ± 7.6 |
| Dipping status, No. (%) | |
| Extreme dipper | 4 (17.4) |
| Dipper | 12 (52.2) |
| Nondipper | 5 (21.7) |
| Riser | 2 (8.7) |
Abbreviations: ARB, angiotensin II receptor blocker; BMI, body mass index; CCB, calcium channel blocker; DBP, diastolic blood pressure; eGFRcreat, creatinine‐based estimated glomerular filtration rate; SBP, systolic blood pressure; UACR, urine albumin to creatinine ratio.
Data are expressed as mean±standard deviation or percentage.